Osterweis Capital Management Inc
Source: SEC Form 13F · as of Mar 2026Osterweis Capital Management Inc holds 20 biotech & pharma companies tracked by BioSniper, totaling $139.4M in value as of Mar 2026 (SEC Form 13F).
Companies held
20
Total value held
$139.4M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 44,788 | $41.2M |
| ABBVAbbVie Inc. | 107,478 | $23.4M |
| GHGuardant Health Inc. | 148,946 | $13.8M |
| VCELVericel Corp | 401,045 | $12.9M |
| RGENREPLIGEN CORP | 92,220 | $10.9M |
| NVSNovartis AG | 69,375 | $10.6M |
| TWSTTwist Bioscience Corp | 211,158 | $10.0M |
| ALHCAlignment Healthcare Inc. | 346,985 | $6.1M |
| COGTCogent Biosciences, Inc. | 150,810 | $5.8M |
| PRCTPROCEPT BioRobotics Corporation | 101,325 | $2.5M |
| JNJJOHNSON & JOHNSON | 4,431 | $1.1M |
| MRKMerck & Co., Inc. | 4,183 | $503K |
| MCKMcKesson Corporation | 226 | $196K |
| ABTABBOTT LABORATORIES | 1,265 | $130K |
| SMMTSummit Therapeutics Inc. | 5,000 | $95K |
| PMPhilip Morris International Inc | 357 | $59K |
| SPRYARS Pharmaceuticals, Inc. | 5,610 | $45K |
| AMGNAMGEN INC | 117 | $41K |
| PLSEPulse Biosciences Inc Common Stock (DE) | 1,000 | $22K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 21 | $9K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.